Clinical Flashcards

1
Q

can cause liver toxicity

A

herbal therapies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

interacts with grapefruit juice

A

simvastatin, pravastatin, atorvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

raises blood pressure

A

licorice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

thyroid medication administration

A

empty stomach 30 min before eating and other meds or 2 hrs after a meal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

administration bisphosphonates

A

empty stomach 1 hr before eating and other meds, cannot lie down

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

functional changes in elderly that impact medications

A
GFR declines 35-50%
body fat increases
serum albumin decreases
hepatic blood decreases
less stomach acid-hard to absorb iron and Ca
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

problems with anticholinergics

A

memory loss and confusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

problems with NSAIDS

A

GI bleeding without warning

give PPI with it (but can cause renal insufficiency)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

problems with benzodiazepines

A

confusion and falls, diazepam can have prolonged half life due to fat soluble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Beers list

A

potentially inappropriate medications for the elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

new recommendations

A

nitrofurantoin until GFR>30
dont use benzos-can use trazodone
avoid PPI greater than 8 weeks, use H2 blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

reduce dose for GFR

A

gabapentin/pregabalin
H2 blockers-rantidine, famotidine
endoxaban/rivaroxaban
avoid NSAIDs if low GFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

life expectancy

A

Hispanic women longest

Black men shortest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

homeostenosis

A

decreased reserve with aging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

body composition changes with aging

A

loss of lean body mass
decrease in skeletal muscle mass
decrease in bone mass
increase in total body adipose tissue-more fat, accumulates in muscles and organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

implications change in body composition changes with aging

A

increase in half life of lipophilic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

temperature change in elderly

A

risk increased for hyper and hypothermia

does not mount fever to infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

body fluid regulation in elderly

A

total body water decreased

thirst sensation diminished

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

blood pressure regulation in elderly

A

higher BPs or orthostatic hypotension

>150/90 acceptable (not HTN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

changes in senses in elderly

A

dark adaptation decreases
near vision declines
high frequency hearing declines
sense of smell declines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

cardiovascular changes in elderly

A
increase wall thickness
decreased elastin
both systolic and diastolic BP increase
adipose infiltrates SA node
calcification-aortic sclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

beta adrenergic stimulation in elderly

A

basal and stress levels of epi and NE are higher

tissue response is diminished

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

neurological system in elderly

A
encoding slower
storage and retrieval slower
decreased multi task
reduction in number and size of spinal cord motor neurons 
decrease nerve terminals and NT release
neuropathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

respiratory changes in elderly

A

decreased elasticity
decreased FEV1
decreased O2 sat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

GI changes in elderly

A

presbyesophagus

hepatic metabolic function may decline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

renal changes in elderly

A

steady decline in most

implications in drug metabolism

27
Q

immune changes in elderly

A

thymic involution-less naive lymphocytes
decreased T cell proliferation
decrease in some cytokines
decreased Ab response to vaccines

28
Q

skeletal changes in elderly

A

loss of cortical thickness
increase in porosity
thinning of trabeculae, loss of trabecular connections

29
Q

shorter elderly

A

war of discs

pathologic-from arthritis or osteoporosis

30
Q

changes in reproductive system

A

vaginal dryness

BPH (avoid alpha agonist decongestants)

31
Q

pain in elderly

A

blunting sensation may minimize complaints

32
Q

HA in elderly

A

uncommon as new complaint

could be from temporal arteritis, trigeminal neuralgia, herpes zoster, subdural hematoma, metastatic disease

33
Q

chest pain in elderly

A

pain causing MSK disorders more common in elderly

Zoster as pain before rash

34
Q

abdominal pain in elderly

A

more life threatening

more serious

35
Q

pneumonia in elderly

A

can present as change in mental status or delirium

36
Q

weakness and fatigue in elderly

A

apathetic hyperthyroidism

takes longer to recover from immobility

37
Q

anorexia and weight loss in elderly

A
malignancy and inflammatory disorders 
CHF or COPD
drug SE
memory loss
depression
hyperthyroidism
38
Q

strategies for demented patient

A
get attention
speak calmly 
use yes or no
repeat and rephrase
do not argue
39
Q

congenital adrenal hyperplasia

A

impaired cortisol synthesis

AR

40
Q

classic CAH

A

salt wasting 75%-hypovolemic shock, hyperkalemia
high risk of adrenal insufficiency
precocious puberty
short stature

41
Q

nonclassic CAH

A

no genital ambiguity
onset in adolescence
angregen excess-oligomenorrhea, hirsutism, acne

42
Q

genetics of 21 hydroxylase locus

A

HLA linkage
6p21.3
point mutations-salt wasting CAH

43
Q

effective treatment CAH

A

glucocorticoid and mineralocorticoid treatment

44
Q

prenatal diagnosis and treatment

A
dexamethasone at risk
chorionic villus sampling at 8-10 weeks
-karyotype, DNA analysis (RFLP, PCR)
amniocentesis at 16 weeks
-karyotype, DNA analysis, HLA typing, amniotic fluid for 17Oh progesterone
45
Q

male treatment

A

stop dexamethasone

46
Q

unaffected females

A

stop dexamethasone

47
Q

affected females

A

continue dexamethasone

48
Q

MEN I

A

parathyroid neoplasia
pituitary neoplasia
pancreatic islet neoplasia
AD

49
Q

MEN II

A

thyrocalcitonin (medullary carcinoma)
pheochromocytoma
parathyroid neoplasia
AD

50
Q

MEN IIa

A

medullary thyroid carcinoma
pheochormocytoma
parathyroid neoplasia

51
Q

MEN IIa variants

A

familial medullary thyroid carcinoma
MEN 2a with cutaneous lichen amyloidosis
MEN 2a with Hirschsprung disease

52
Q

MEN IIb

A

medullary thyroid carcinoma
pheochromocytoma

marfinoid habitus, intestinal ganlioneuromatosis and mucosal neuromas

53
Q

medullary thyroid carcinoma

A

neoplasm of follicular cells
secretes cacitonin, CEA
hyperpalsia to nodular to micro carcinoma to macro carcinoma
most common in MEN 2B
death-airway obstruction, liver and lung mets

54
Q

RET proto-oncogene

A

tyrosine kinase receptor
knocks out-GI, kidney, sympathetic nervous system
interacts with glial cell-derived neutrophic factor

55
Q

MEN 2a screening

A

pentagastrin stimulated calcitonin and 24 h urine metanephrines yearly
calcium biyearly

56
Q

familial medullary throid carcinoma

A

no RET mutation

annual calcitonin and neck US

57
Q

steps involved in work up of genetic patient

A
history
examination
testing
establishment of diagnosis
counseling
58
Q

family history

A

pedigree-3 generations
include miscarriages
ask about consanguinity
inquire about ethnic origins

59
Q

testing for chromosomes

A

routine
high resolution
microdeletion FISH
microarray CGH

60
Q

molecular/DNA testing

A

disease specific testing

whole geneome/exome sequencing

61
Q

metabolic studies

A

amino acids

organic acids

62
Q

microdeletion syndromes

A
Williams
Langer-Giedion
WAGR
Prader-Willi
Angelman
Smith Magines
Miller Dieker
Retinoblastoma
DiGeorge
VeloCardioFacial
63
Q

Ashkenazi Jew disorders

A
Tay Sachs
Canavan
familial dysautonomia
Fanconi anemia C
NP type A
Bloom syndrome
mucolipidosis IV
Gaucher
CF